alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM
THERMA-WAVE, INC.'S FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          MAR-31-1998
<PERIOD-START>                             APR-01-1997
<PERIOD-END>                               DEC-31-1997
<CASH>                                          15,827
<SECURITIES>                                         0
<RECEIVABLES>                                   22,649
<ALLOWANCES>                                     2,610
<INVENTORY>                                     20,571
<CURRENT-ASSETS>                                66,628
<PP&E>                                           6,595
<DEPRECIATION>                                   1,482
<TOTAL-ASSETS>                                  85,329
<CURRENT-LIABILITIES>                           23,821
<BONDS>                                        115,000
<PREFERRED-MANDATORY>                           14,308
<PREFERRED>                                          0
<COMMON>                                           114
<OTHER-SE>                                     (70,776)
<TOTAL-LIABILITY-AND-EQUITY>                    85,329
<SALES>                                         86,155
<TOTAL-REVENUES>                                86,155
<CGS>                                           40,974
<TOTAL-COSTS>                                   40,974
<OTHER-EXPENSES>                                37,159
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               9,362
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                      (347)
<INCOME-CONTINUING>                               (546)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      (546)
<EPS-PRIMARY>                                        0
<EPS-DILUTED>                                        0
        

</TABLE>
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This schedule contains summary financial information
extracted from the Balance Sheet, and Income Statement
and is qualified in its entirety by reference to such 
financial statements.
</LEGEND>
<CIK>                                       0000911148
<NAME>                      Cadus Pharmaceutical Corp.
<MULTIPLIER>                                     1,000
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          Dec-31-1996
<PERIOD-START>                             Jan-01-1996
<PERIOD-END>                               Dec-31-1996
<CASH>                                      43,152,677
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                            43,415,729
<PP&E>                                       4,443,545
<DEPRECIATION>                               1,488,015
<TOTAL-ASSETS>                              47,286,858
<CURRENT-LIABILITIES>                        1,939,055
<BONDS>                                         16,474
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       122,029
<OTHER-SE>                                  45,059,300
<TOTAL-LIABILITY-AND-EQUITY>                47,286,858
<SALES>                                              0
<TOTAL-REVENUES>                             6,500,000
<CGS>                                                0
<TOTAL-COSTS>                               10,597,549
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             110,416
<INCOME-PRETAX>                             (2,378,145)
<INCOME-TAX>                                    62,580
<INCOME-CONTINUING>                         (2,440,725)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                (2,440,725)
<EPS-PRIMARY>                                    (0.39)
<EPS-DILUTED>                                    (0.24)
        


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               DEC-31-2000
<CASH>                                            7630
<INT-BEARING-DEPOSITS>                             292
<FED-FUNDS-SOLD>                                     0
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                          0
<INVESTMENTS-CARRYING>                          013714
<INVESTMENTS-MARKET>                             13714
<LOANS>                                         185969
<ALLOWANCE>                                       1175
<TOTAL-ASSETS>                                  216652
<DEPOSITS>                                      183631
<SHORT-TERM>                                      3840
<LIABILITIES-OTHER>                               2658
<LONG-TERM>                                       8600
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                          7198
<OTHER-SE>                                       10726
<TOTAL-LIABILITIES-AND-EQUITY>                  216652
<INTEREST-LOAN>                                   4249
<INTEREST-INVEST>                                  224
<INTEREST-OTHER>                                     4
<INTEREST-TOTAL>                                  4477
<INTEREST-DEPOSIT>                                1876
<INTEREST-EXPENSE>                                2061
<INTEREST-INCOME-NET>                             2416
<LOAN-LOSSES>                                       30
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                   2012
<INCOME-PRETAX>                                   1000
<INCOME-PRE-EXTRAORDINARY>                        1000
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       600
<EPS-BASIC>                                        .08
<EPS-DILUTED>                                      .08
<YIELD-ACTUAL>                                    4.94
<LOANS-NON>                                       1790
<LOANS-PAST>                                         0
<LOANS-TROUBLED>                                     0
<LOANS-PROBLEM>                                      0
<ALLOWANCE-OPEN>                                  1236
<CHARGE-OFFS>                                      115
<RECOVERIES>                                        25
<ALLOWANCE-CLOSE>                                 1175
<ALLOWANCE-DOMESTIC>                                 0
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                              0


</TABLE>
IIA

103D CONGRESS

1ST SESSION H. R. 2074

IN THE SENATE OF THE UNTIED STATES

SEPTEMBER 22 (legislative day, SEPTEMBER 7), 1993

Received

AN ACT

To authorize appropriations for the American Folklife Center

for fiscal years 1994 and 1995.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. AUTHORIZATION OF APPROPRIATIONS FOR

4 THE AMERICAN FOLKLIFE CENTER.

5 Section 8 of the American Folklife Preservation Act

6 (20 U.S.C. 2107) is amended—

7 (1) by striking out ‘‘and’’ after ‘‘September 30,

8 1992,’’; and
2

•HR 2074 RDS

1 (2) by inserting after ‘‘September 30, 1993’’

2 the following: ‘‘, $1,120,000 for the fiscal year end3 ing September 30, 1994, and $1,120,000 for the fis4 cal year ending September 30, 1995’’.

Passed the House of Representatives September 21,

1993.

Attest: DONNALD K. ANDERSON,

Clerk.
```

[Congressional Bills 103th Congress]
[From the U.S. Government Publishing Office]
[H.R. 2087 Introduced in House (IH)]

103d CONGRESS
  1st Session
                                H. R. 2087

    To extend the temporary suspension of duty on 1-[1-((4-Chloro-2-
(trifluoromethyl)-phenyl)imino)-2-propoxyethyl]-1-H-imidazole, and for 
                            other purposes.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 12, 1993

Mrs. Johnson of Connecticut (by request) introduced the following bill; 
         which was referred to the Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
    To extend the temporary suspension of duty on 1-[1-((4-Chloro-2-
(trifluoromethyl)-phenyl)imino)-2-propoxyethyl]-1-H-imidazole, and for 
                            other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. EXTENSION OF EXISTING SUSPENSION OF DUTY ON 1-[1-((4-CHLORO-
              2-(TRIFLUORO- METHYL)-PHENYL)IMINO)-2-PROPOXYETHYL]-1-H-
              IMIDAZOLE.

    (a) In General.--Heading 9902.31.07 of the Harmonized Tariff 
Schedule of the United States is amended by--
            (1) inserting ``(triflumizole)'' after ``1-[1-((4-Chloro-2-
        (trifluoromethyl)-phenyl)imino)-2-propoxy- ethyl]-1-H-
        imidazole''; and
            (2) striking ``12/31/92'' and inserting ``12/31/98''.
    (b) Effective Date.--
            (1) In general.--The amendments made by subsection (a) 
        apply with respect to goods entered, or withdrawn from 
        warehouse for consumption, on or after the 15th day after the 
        date of the enactment of this Act.
            (2) Retroactive application to certain entries.--
        Notwithstanding section 514 of the Tariff Act of 1930 (19 
        U.S.C. 1514) or any other provision of law, upon proper request 
        filed with the appropriate customs officer before the 90th day 
        after the date of the enactment of this Act, any entry, or 
        withdrawal from warehouse for consumption, of any goods 
        described in heading 9902.31.07 (as amended by subsection 
        (a)(1)) of the Harmonized Tariff Schedule of the United States 
        that was made--
                    (A) after December 31, 1992; and
                    (B) before the 15th day after the date of the 
                enactment of this Act;
        shall be liquidated or reliquidated as though such entry or 
        withdrawal occurred on the 15th day after the date of the 
        enactment of this Act.

                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the
consolidated balance sheet as af August 26, 2000 and the consolidated
statement of income for the twelve weeks ended August 26, 2000 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-02-2001
<PERIOD-END>                               AUG-26-2000
<CASH>                                               0
<SECURITIES>                                         0
<RECEIVABLES>                                  208,430
<ALLOWANCES>                                     4,483
<INVENTORY>                                     81,321
<CURRENT-ASSETS>                               348,415
<PP&E>                                       1,405,330
<DEPRECIATION>                                 523,183
<TOTAL-ASSETS>                               1,651,800
<CURRENT-LIABILITIES>                          322,936
<BONDS>                                        412,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           798
<OTHER-SE>                                     573,142
<TOTAL-LIABILITY-AND-EQUITY>                 1,651,800
<SALES>                                        819,694
<TOTAL-REVENUES>                               819,694
<CGS>                                          384,220
<TOTAL-COSTS>                                  384,220
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               6,721
<INCOME-PRETAX>                                 43,574
<INCOME-TAX>                                    16,689
<INCOME-CONTINUING>                             26,885
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    26,885
<EPS-BASIC>                                        .41
<EPS-DILUTED>                                      .41


</TABLE>
<PAGE>


                                                                    EXHIBIT 32.2


                           SECTION 1350 CERTIFICATIONS

Pursuant to 18 U.S.C. ss. 1350, as created by Section 906 of the Sarbanes-Oxley
Act of 2002, the undersigneD officer of Strategic Diagnostics Inc. (the
"Company") hereby certifies, to such officer's knowledge, that:

        (i)     the accompanying Annual Report on Form 10-K of the Company for
                the period ended December 31, 2006 (the "Report") fully complies
                with the requirements of Section 13(a) or Section 15(d), as
                applicable, of the Securities Exchange Act of 1934, as amended;
                and

        (ii)    the information contained in the Report fairly presents, in all
                material respects, the financial condition and results of
                operations of the Company.

The foregoing certification is being furnished solely to accompany the Report
pursuant to 18 U.S.C. ss. 1350, and is not being filed for purposes of Section
18 of the Securities Exchange Act of 1934, as amended, and is not to be
incorporated by reference into any filing of the Company, whether made before or
after the date hereof, regardless of any general incorporation language in such
filing.

Date: April 2, 2007       By:
                             /s/ Stanley Fronczkowski
                             ---------------------------------------------------
                             STANLEY FRONCZKOWSKI
                             VICE PRESIDENT--FINANCE AND CHIEF FINANCIAL OFFICER
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 13-7057

UNITED STATES OF AMERICA, 

 Plaintiff - Appellee, 

v. 

KYHEIM DELANGO TUCKER, a/k/a Paso, 

 Defendant - Appellant. 

Appeal from the United States District Court for the Eastern 

District of Virginia, at Newport News. Rebecca Beach Smith, 

Chief District Judge. (4:09-cr-00081-RBS-FBS-11; 4:13-cv-00033-

RBS) 

Submitted: August 29, 2013 Decided: September 4, 2013

Before DUNCAN, AGEE, and KEENAN, Circuit Judges. 

Remanded by unpublished per curiam opinion. 

Kyheim Delango Tucker, Appellant Pro Se. Eric Matthew Hurt, 

Lisa Rae McKeel, Brian James Samuels, Howard Jacob Zlotnick, 

Assistant United States Attorneys, Newport News, Virginia, for 

Appellee. 

Unpublished opinions are not binding precedent in this circuit. 
2

PER CURIAM: 

Kyheim Delango Tucker, a federal prisoner, seeks to 

appeal the district court’s order dismissing as untimely his 

28 U.S.C.A. § 2255 (West Supp. 2013) motion. In a civil case in 

which the United States or its officer or agency is a party, the 

notice of appeal must be filed no more than sixty days after the 

entry of the district court’s final judgment or order, Fed. R. 

App. P. 4(a)(1)(B), unless the district court extends the appeal 

period under Fed. R. App. P. 4(a)(5), or reopens the appeal 

period under Fed. R. App. P. 4(a)(6). 

The district court’s order was entered on the docket 

on April 19, 2013. The notice of appeal was filed on June 22, 

2013,* after the expiration of the sixty-day appeal period but 

within the thirty-day excusable neglect period. In the notice 

of appeal, Tucker acknowledges that his appeal is untimely but 

requests that the notice be “grant[ed]” because he was 

experiencing money “problems” and awaiting a determination by 

prison authorities as to whether he qualified as indigent and 

eligible to receive postage to mail the notice to the court. 

 * For the purpose of this appeal, we assume that the date 

appearing on the notice of appeal is the earliest date it could 

have been properly delivered to prison officials for mailing to 

the court. Fed. R. App. P. 4(c); Houston v. Lack, 487 U.S. 266, 

276 (1988). 
3

We liberally construe Tucker’s statements as 

requesting an extension of the appeal period under Fed. R. App. 

P. 4(a)(5). Washington v. Bumgarner, 882 F.2d 899, 900–01 

(4th Cir. 1989); Myers v. Stephenson, 748 F.2d 202, 204 

(4th Cir. 1984). Because the district court has not ruled on 

the request for extension, we remand the case to the district 

court for the limited purpose of determining whether Tucker has 

demonstrated excusable neglect or good cause warranting an 

extension of the sixty-day appeal period. The record, as 

supplemented, will then be returned to this court for further 

consideration. 

REMANDED
<PAGE>

                   EXHIBIT 23.1 - CONSENT OF INDEPENDENT AUDITORS
=============================================================================== 

  We consent to the incorporation by reference in this Annual Report (Form 10-K)
  of Ultimate Electronics, Inc. of our report dated March 7, 1997, included in 
  the 1997 Annual Report to Stockholders of Ultimate Electronics, Inc.

  Our audits also included the financial statement schedule of Ultimate
  Electronics, Inc. listed in Item 14(a).  This schedule is the responsibility
  of the Company's management.  Our responsibility is to express an opinion
  based on our audits.  In our opinion, the financial statement schedule
  referred to above, when considered in relation to the basic financial
  statements as a whole, presents fairly in all material respects the
  information set forth therein.

  We also consent to the incorporation by reference in the Registration
  Statements on Form S-8 (No. 33-94636, No. 33-92256 and No. 33-92258)
  pertaining to the SoundTrack 401(k) Retirement Savings Plan, the Non-employee
  Director Stock Option Plan and the Employee Stock Option Plan, respectively,
  of Ultimate Electronics, Inc. of our report dated March 7, 1997 with respect
  to the financial statements and schedule of Ultimate Electronics, Inc.
  included or incorporated by reference in this Annual Report (Form 10-K) for
  the year ended January 31, 1997.



          Ernst & Young LLP

  Denver, Colorado
  April 8, 1997
Fourth Court of Appeals

San Antonio, Texas

JUDGMENT

No. 04-19-00793-CV

CITY OF SAN ANTONIO,

Appellant

v.

Tanya WALKER,

Appellee

From the 73rd Judicial District Court, Bexar County, Texas

Trial Court No. 2018CI23121

Honorable David A. Canales, Judge Presiding

BEFORE JUSTICE CHAPA, JUSTICE RIOS, AND JUSTICE WATKINS

In accordance with this court’s opinion of this date, the parties’ joint motion to reinstate is 

granted. This appeal is reinstated on this court’s active docket. The trial court’s order denying the 

City of San Antonio’s plea to the jurisdiction is VACATED, and we RENDER an order dismissing 

all of Tanya Walker’s claims against the City of San Antonio with prejudice. Costs of this appeal 

are assessed against the party incurring the same.

SIGNED August 5, 2020.

_________________________________

Luz Elena D. Chapa, Justice
MEMORANDUM OPINION

Nos. 04-11-00348-CR & 04-11-00349-CR

Norman Gary PICKENS,

Appellant

v.

The STATE of Texas,

Appellee

From the 227th Judicial District Court, Bexar County, Texas

Trial Court No. 2009CR2384

Honorable Philip A. Kazen, Jr., Judge Presiding

PER CURIAM

Sitting: Rebecca Simmons, Justice

Steven C. Hilbig, Justice

Marialyn Barnard, Justice

Delivered and Filed: August 3, 2011

DISMISSED

In each of the trial court’s certifications in these appeals, the certification states that the 

case is “plea-bargain case, and the defendant has NO right of appeal.” We must dismiss an 

appeal “if a certification that shows the defendant has a right of appeal has not been made part of 

the record.” TEX. R. APP. P. 25.2(d); Dears v. State, 154 S.W.3d 610, 613 (Tex. Crim. App. 

2005). 
04-11-00348-CR & 04-11-00349-CR

- 2 -

In each case, Appellant’s counsel has filed written notice with this court that counsel has 

reviewed the record and “can find no right of appeal for Appellant.” We construe this notice as 

an indication that appellant will not seek to file an amended trial court certification showing that 

appellant has the right of appeal. See TEX. R. APP. P. 25.2(d); 37.1; see also Daniels v. State, 110 

S.W.3d 174, 177 (Tex. App.—San Antonio 2003, no pet.). In light of the records presented, we 

agree with Appellant’s counsel that Rule 25.2(d) requires this court to dismiss these appeals. 

Accordingly, these appeals are dismissed.

PER CURIAM

DO NOT PUBLISH
Order entered November 22 , 2019

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05

- 19

- 00201

- CV

RICHARD RALEY , RALEY HOLDINGS, LLC , AND MATTHEW W. BOBO, Appellant s

V.

DANIEL K. HAGO OD, P.C. AND FITZPAT RICK HAGOOD SMITH & UHL, LLP, Appellee s
On Appeal from the County Court at Law No. 2

Dallas County, Texas Trial Court Cause No. CC

- 17

- 00390

- B



### O RDER

Before the Court is appellants’ November 18, 2019 unopposed motion for a fourteen

- day
extension of time to file their opening brief

. We GRANT the motion and ORDER appellants’
opening brief be filed no later than December 6, 2019.

/s/ BILL WHITEHILL JUSTICE
**EXHIBIT32.0**

 

# **SECTION 1350CERTIFICATION**

 

The undersigned hereby certify that this reportcomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934, and that the information contained in this reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company.

 

 
| Dated: March 28, 2008 | By:                                   | /s/ Roger E. Gower |
|----------------------------|---------------------------------------|--------------------|
|                       | Roger E. Gower                        |
|                       | President and Chief Executive Officer |

 
| Dated: March 28, 2008 | By:                     | /s/ Bruce R. Ficks |
|----------------------------|-------------------------|--------------------|
|                       | Bruce R. Ficks          |
|                       | Chief Financial Officer |

 

 

----